Table 1.
Strategy | Metabolite | Immune Pathway | Outcome | Ref |
---|---|---|---|---|
Micronutrient supplementation | Vitamin D | (AMPS) cathelicidins | Promote resistance | 163, 164, 165 |
Vitamin A | Autophagy, lipid metabolism | |||
Macronutrients supplementation | Glutamine | Metabolic reprogramming, | Promote resistance | 166, 167 |
Arginine | NO production | Modulate tolerance | ||
Macronutrient depletion | Tryptophan | Mycobacterial metabolism, granuloma formation | Promote tolerance | 168 |
Microbial metabolites | SCFA | Anti‐inflammatory | Modulate tolerance | 173, 174 |
IPA | Promote resistance | |||
Repurposing small molecule | Rapamycin analogues (everolimus) | mTOR/AKT1 glycolytic reprogramming | Modulate tolerance | 56, 169 |
Targeting whole‐body metabolism | Metformin | Modulate hyperglycaemia, autophagy, cytokine production | Modulate tolerance | 170, 171, 172 |
Statins | Macrophage foam cells | Promote resistance | ||
Promote immune training | BCG | Promote bone marrow myeloid expansion | Increased resistance | 153, 154 |
Beta‐glucans |
Abbreviations: AMPK, AMP protein kinase; AMPs, antimicrobial peptides; BCG, bacille Calmette–Guérin vaccine; HMGCR, HMG‐CoA reductase; IPA, indole‐3‐propionic acid; NO, nitric oxide; SCFA, short‐chain fatty acids.